Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5045552 | WOODWARD | Pyridine derivatives having anti-ulcerative activity |
May, 2013
(10 years ago) | |
US5045552 (Pediatric) | WOODWARD | Pyridine derivatives having anti-ulcerative activity |
Nov, 2013
(10 years ago) |
Market Authorisation Date: 29 May, 2002
Treatment: Treatment of peptic ulcers
Dosage: TABLET, DELAYED RELEASE;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5045552 | AYTU | Pyridine derivatives having anti-ulcerative activity |
May, 2013
(10 years ago) | |
US5045552 (Pediatric) | AYTU | Pyridine derivatives having anti-ulcerative activity |
Nov, 2013
(10 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
Pediatric Exclusivity(PED) | Sep 26, 2016 |
New Dosage Form(NDF) | Mar 26, 2016 |
Market Authorisation Date: 26 March, 2013
Treatment: Treatment of peptic ulcers
Dosage: CAPSULE, DELAYED RELEASE;ORAL